A large-scale analysis of refractive errors in students attending public primary schools in Mexico.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
19 08 2023
Historique:
received: 13 04 2023
accepted: 16 08 2023
medline: 21 8 2023
pubmed: 20 8 2023
entrez: 19 8 2023
Statut: epublish

Résumé

A cross-sectional, retrospective study was conducted from September 2013 through July 2014 to determine the prevalence of refractive errors among students attending public primary schools in Mexico. Among 3,861,156 students at 14,566 public primary schools in all 32 states of Mexico, teachers identified reduced visual acuity in 1,253,589 (32.5%) using visual acuity measurement. Optometrists confirmed 391,498 [31.2%, mean (SD) age: 8.8 (1.9) years; 204,110 girls (52.9%)] had refractive errors using visual acuity measurement and noncycloplegic static retinoscopy. Among 288,537 (72.4%) of children with previous eyeglasses usage data reported, 241,505 (83.7%) had uncorrected refractive errors. Before prescription eyeglasses were provided, 281,891 students (72%) had logMAR visual acuity ≤ 0.2; eyeglasses corrected vision loss in 85.6% (n = 241,352) of them. Simple myopic astigmatism was the most frequent refractive error (25.7%, n = 100,545). Astigmatism > - 1.00 diopters was present in 54.6% of all students with ametropia. The anisometropia rate based on spherical equivalent difference between right and left eye ≥ 1.50 diopters was 3.9% (n = 15,402). Uncorrected refractive errors are an important issue in primary school students in Mexico. An updated study is needed to analyze the evolving trends over the past decade.

Identifiants

pubmed: 37598286
doi: 10.1038/s41598-023-40810-5
pii: 10.1038/s41598-023-40810-5
pmc: PMC10439951
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

13509

Informations de copyright

© 2023. Springer Nature Limited.

Références

Br J Ophthalmol. 2005 Mar;89(3):360-3
pubmed: 15722319
Surv Ophthalmol. 2012 May-Jun;57(3):272-83
pubmed: 22398336
BMC Ophthalmol. 2020 Jan 14;20(1):27
pubmed: 31937276
Can J Ophthalmol. 2020 Feb;55(1):52-57
pubmed: 31712026
Sci Rep. 2022 Mar 8;12(1):4069
pubmed: 35260753
Indian J Ophthalmol. 2022 Aug;70(8):3040-3044
pubmed: 35918969
Am J Ophthalmol. 2021 Mar;223:333-337
pubmed: 32738229
Rev Panam Salud Publica. 2018 May 04;42:e61
pubmed: 31093089
Acad Pediatr. 2020 Sep - Oct;20(7):910-916
pubmed: 31926990
Invest Ophthalmol Vis Sci. 2007 Nov;48(11):4949-54
pubmed: 17962444
Lancet Glob Health. 2022 Dec;10(12):e1754-e1763
pubmed: 36240807
Salud Publica Mex. 2005 Jul-Aug;47(4):258
pubmed: 16259285
Health Policy. 2009 Feb;89(2):201-15
pubmed: 18621429
J Cataract Refract Surg. 2011 Mar;37(3):454-60
pubmed: 21333869
J Optom. 2021 Oct-Dec;14(4):328-334
pubmed: 34167928
Lancet Glob Health. 2021 Feb;9(2):e130-e143
pubmed: 33275950
J Curr Ophthalmol. 2017 Sep 27;30(1):3-22
pubmed: 29564404
Acta Ophthalmol. 2015 Sep;93(6):581-5
pubmed: 25597549
Graefes Arch Clin Exp Ophthalmol. 2019 Aug;257(8):1805
pubmed: 31222407
Cureus. 2022 Aug 26;14(8):e28444
pubmed: 36176879
Invest Ophthalmol Vis Sci. 2012 Jun 20;53(7):3782-7
pubmed: 22589429
Clin Exp Optom. 2023 Apr;106(3):322-330
pubmed: 35021950
Br J Ophthalmol. 2018 Oct;102(10):1407-1412
pubmed: 29437571
Invest Ophthalmol Vis Sci. 2006 Mar;47(3):925-8
pubmed: 16505025
Prog Retin Eye Res. 2013 Sep;36:120-58
pubmed: 23773832
Optom Vis Sci. 2004 Jan;81(1):49-55
pubmed: 14747761
Ophthalmology. 2007 Feb;114(2):374-82
pubmed: 17123622
F1000Res. 2021 Nov 1;10:1101
pubmed: 35035896
BMJ Open. 2022 Aug 3;12(8):e062388
pubmed: 35922104
Ophthalmology. 2016 May;123(5):1036-42
pubmed: 26875007
Asia Pac J Ophthalmol (Phila). 2022 Sep 01;11(5):470-480
pubmed: 36179338
Rev Med Inst Mex Seguro Soc. 2009 Jan-Feb;47(1):39-44
pubmed: 19624963
Ophthalmic Physiol Opt. 2015 Jan;35(1):8-18
pubmed: 25424167
J Policy Anal Manage. 2018;37(2):265-300
pubmed: 29693366
PLoS One. 2022 Jul 1;17(7):e0268800
pubmed: 35776717
Front Public Health. 2022 Jul 22;10:835449
pubmed: 35937221
J Formos Med Assoc. 2020 Aug;119(8):1251-1258
pubmed: 32354691
Invest Ophthalmol Vis Sci. 2006 Jan;47(1):55-64
pubmed: 16384944
Cochrane Database Syst Rev. 2018 Feb 15;2:CD005023
pubmed: 29446439
Int J Ophthalmol. 2019 Jul 18;12(7):1194-1201
pubmed: 31341813
Lancet Glob Health. 2021 Feb;9(2):e144-e160
pubmed: 33275949
JAMA Ophthalmol. 2021 Oct 01;139(10):1104-1114
pubmed: 34499111
Children (Basel). 2022 Jun 19;9(6):
pubmed: 35740857
Int J Ophthalmol. 2019 Oct 18;12(10):1612-1617
pubmed: 31637198

Auteurs

Marco Antonio Ramírez-Ortiz (MA)

Ophthalmology Department, Hospital Infantil de México Federico Gómez, Mexico City, Mexico.

Mónica Amato-Almanza (M)

Ophthalmology Department, Hospital Infantil de México Federico Gómez, Mexico City, Mexico.

Iván Romero-Bautista (I)

School of Optometry, UNAM-FES Iztacala, Tlalnepantla, State of Mexico, Mexico.

Miguel Klunder-Klunder (M)

Research Division, Hospital Infantil de México Federico Gómez, Mexico City, Mexico.

Oswaldo Aguirre-Luna (O)

Ophthalmology Department, Hospital Infantil de México Federico Gómez, Mexico City, Mexico.

Iryna Kuzhda (I)

Ophthalmology Department, Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine.

Serge Resnikoff (S)

Brien Holden Vision Institute, Sydney, NSW, Australia.
School of Optometry and Vision Science, University of New South Wales, Sydney, NSW, Australia.

Kristen Allison Eckert (KA)

Independent Consultant, San Antonio Tlayacapan, Jalisco, Mexico.

Van Charles Lansingh (VC)

Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA. van.lansingh@imoiap.edu.mx.
HelpMeSee, New York, NY, USA. van.lansingh@imoiap.edu.mx.
See Better to Learn Better Foundation, Mexico City, Mexico. van.lansingh@imoiap.edu.mx.
Instituto Mexicano de Oftalmología, Av. Armando Birlain Shaffler S/N, Centro Sur, 76090, Santiago de Querétaro, QRO, Mexico. van.lansingh@imoiap.edu.mx.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH